MedTrace Logo

Circuit Training on Vertigo, Oscillopsia and Dizziness in Vestibular Hypo Function Hypo- Functions

NCT04261283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-03-30

No results posted yet for this study

Summary

In this research, the main purpose is to determine the effects of Circuit Training consisting of Structured Vestibular rehabilitation Program under the strict supervision of Neuro-Therapist versus Medicines and General (simple) Rehabilitation (only Home-based) in community-dwelling population of people diagnosed with Vestibular disorders. A booklet consisting of general instructions, simple vestibular exercises which are to be made a part of daily routine, specific diet plan and specific precautions to be taken by patients reporting with vertigo, oscillopsia and dizziness will also be provided to all the patients. This is a community service addition, added so that everyone in the society can have easy access to the instructions, will be cost effective, and will reduce their visits to the therapist.

Conditions

  • Vestibular Disorder

Interventions

OTHER

Experimental

The Circuit Training will be consisting of: 1. Habituation Exercises 2. Exercises for the gaze stability (The two exercises are specifically for the patients who reported a high score on oscillopsia severity questionnaire 3. Exercises to improve Saccade Latency. 4. Adaptation Exercises 5. Substitution Exercises 6. Postural Control Exercises 7. General Conditioning Activities 8. Cawthorne-Cooksey Exercises 9. Ocular Motor Exercises 10. Gait Exercises 11. Treatment to Decrease Sensitivity to Motion in the Environment

OTHER

Active Comparator

Medicines as prescribed by the ear, nose, and throat (ENT) specialist and Home-based exercise Programme (Simple and general vestibular rehabilitation exercises) will be recommended to the patients to perform. ( Not under the supervision of neuro-therapist)

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Arshad Nawaz AN Malik, PhD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04261283 on ClinicalTrials.gov